Status:

COMPLETED

Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy

Lead Sponsor:

Germans Trias i Pujol Hospital

Collaborating Sponsors:

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

Conditions:

HIV Infections

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Basing in studies which have related the darunavir (DRV) virtual inhibitory quotient (vIQ) with the virological response, it is possible to think in the possibility of simplifying the rescue treatment...

Detailed Description

The probability of achieving viral replication suppression during the treatment with DRV has been related to both the extent of viral resistance to DRV (inhibitory concentration 50%, IC50) and the dru...

Eligibility Criteria

Inclusion

  • Age \>= 18 years.
  • HIV-infected patients.
  • Stable antiretroviral treatment including darunavir/ritonavir 600/100 every 12 hours for at least 4 weeks.
  • HIV viral load \< 50 copies/mL for at least 12 weeks.
  • Resistance test (Genotype or Virtual Phenotype) before starting tipranavir treatment.
  • Darunavir vIQ \>= 2.
  • Subject able to follow the treatment period.
  • In women, negative pregnancy test or not in fertile age (defined as at least one year from menopause or undergoing any surgical sterilisation technique), or undertaking to use a barrier contraceptive method during the study.
  • Signature of the informed consent.

Exclusion

  • AIDS-defining illness in the last 4 weeks.
  • Suspicion of unsuitable antiretroviral treatment compliance.
  • In women, pregnancy or breastfeeding.
  • Record or suspicion of incapability to cooperate as appropriate.

Key Trial Info

Start Date :

February 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2009

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00611039

Start Date

February 1 2008

End Date

July 1 2009

Last Update

December 5 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Germans Trias i Pujol Hospital

Badalona, Barcelona, Spain, 08916